United States · Venture startup

Who invested in Pace mate

One round we have observed, with the 0 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Healthcare

Funding summaryUpdated 26 Oct 2026

Undisclosedraised across 1 round since 2023, from 1 source

Latest round
VentureJul 2023
Investors
0
See who backed them

The rounds

  1. Jul 2023
    VentureAmount undisclosed

    No investor was named in the report.

    Source recorded

Founders and team

From Pace mate's own website: 4 founders, 6 on the team.

Jason HaleSenior Vice President of Commercial Excellence and Co-Founder
Noemi RaySenior Vice President of Clinical Operations and Co-Founder
Gabe RosuChief Technology Officer and Co-Founder
Tripp HigginsChairman of the Board and Co-Founder
  • Chandler YoqueletPresident and Chief Financial Officer
  • McCullough BuchananVice President of People and Culture
  • Ryan BaroneSenior Vice President of Sales and Marketing
  • Dr. Benjamin SteinbergChief Medical Officer
  • Sean ShoffstallChief Product Officer
  • Brian FaulknierHead of Customer Operations

AdvisersTina Baykaner

Also claim to have backed them

These 2 firms list Pace mate as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

Ballast Point VenturesPrivate equityPer its own site
Ballast Point PartnersGrowth equityPer its own site

Quick answers about Pace mate

How much has Pace mate raised?

Pace mate has raised 1 round since 2023, none with a disclosed amount.

When did Pace mate last raise?

Pace mate's most recent round was a Venture in Jul 2023.

What stage is Pace mate at?

Pace mate's latest named round is a Venture, in Jul 2023.

Where is Pace mate based?

Pace mate is based in the United States.

Companies like Pace mate

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.